Petiti, J. P., Sosa, L. d. V., Picech, F., Moyano Crespo, G. D., Arevalo Rojas, J. Z., Pérez, P. A., . . . Torres, A. I. (2023). Trastuzumab inhibits pituitary tumor cell growth modulating the TGFB/SMAD2/3 pathway. Society for Endocrinology.
Cita Chicago Style (17a ed.)Petiti, Juan Pablo, et al. Trastuzumab Inhibits Pituitary Tumor Cell Growth Modulating the TGFB/SMAD2/3 Pathway. Society for Endocrinology, 2023.
Cita MLA (8a ed.)Petiti, Juan Pablo, et al. Trastuzumab Inhibits Pituitary Tumor Cell Growth Modulating the TGFB/SMAD2/3 Pathway. Society for Endocrinology, 2023.
Precaución: Estas citas no son 100% exactas.